Fresh Rounds

Mangrove Therapeutics Inc. funding

Mangrove Therapeutics Inc., a biotechnology company based in Sacramento, CA (founded 2025), filed a Form D with the SEC on July 31, 2026 and reported $2.5M raised of a $5M offering.

Amount raised$2.5M
Offering size$5M
Filed with the SECJuly 31, 2026
First saleJuly 21, 2026
IndustryBiotechnology
SecuritiesOther
LocationSacramento, CA
Founded2025
Entity typeCorporation
Investors so far9
Minimum investment$25K
Revenue rangeNo Revenues

Other health care rounds in California